Lawyers say a trade group’s new sales and marketing code of ethics for pharmaceutical companies that’s designed to help companies avoid government investigations and prosecutions will trigger extensive corporate governance work on behalf of participating companies.
The Pharmaceutical Research and Manufacturers of America (PhRMA), a trade organization for drug makers and research companies, announced a massive overhaul of its ethics code governing companies’ interactions with health care professionals, which will become effective in January 2009.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
